🇺🇸 FDA
Patent

US 10342764

Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same

granted A61KA61K38/17A61K38/26

Quick answer

US patent 10342764 (Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same) held by Oramed Ltd. expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Oramed Ltd.
Grant date
Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K38/17, A61K38/26, A61K38/28, A61K38/56